Contrarian read not yet authored for this shift. The wedge section will name the consensus position, our differing read, and the structural reason for the divergence.
§ Thesis
What's actually shifting.
Bipartisan US consensus has crystallized around strategic decoupling in semiconductors, advanced manufacturing, AI, biotech, and critical minerals. This is structural, not cyclical, and survives administration changes. The reshoring dividend goes to specific corridors (Mexico, Vietnam, India, Eastern Europe) and specific technology stacks; pure China-export plays face a structural headwind regardless of valuation. The pace of decoupling is set by industrial-policy lag and supply-chain inertia, not by political appetite — so the trajectory is largely locked in for 5-10 years.
Critical-minerals processing — rare earths, gallium, germanium, lithium-refining outside China
Eastern European auto-parts and industrial-component manufacturers
Australian critical-minerals miners with Western-aligned offtake
India-domiciled tech-services with US client books and Indian engineering pipeline
Defense-industrial-base specialists with government-procurement leverage
Trapped sectors
China-domiciled semiconductor design and IP-licensing
Apple-supplier ecosystem with single-China assembly exposure
Taiwan-strait-risk-concentrated supply chains without Diversification path
Multinationals with >40% China revenue exposure and no India / Vietnam / Mexico pivot in motion
Dual-listed Chinese ADRs facing delisting and capital-flight pressure
§ Named positions — specific entities
Where the categorical reads land in particular names.
Specific named positions not yet authored. This section will carry tickers / companies / asset-class names with thesis, risk, and sizing notes — the difference between a category read and a position read.
§ Signal tracking
What would tell you the shift is accelerating — or stalling.
Watch for (acceleration)
Mexico FDI inflow vs Chinese outflow (the leading reshoring indicator)
Indian PLI-scheme uptake by category (electronics, pharma, semis)
Expanding outbound-investment restrictions (semis → biotech → AI → ?)
Taiwan-strait incidents with even minor escalatory signaling
Critical-minerals-processing announcements outside China
Anti-watch-for (stalling / reversal)
G2 thaw scenario (low probability but watch back-channel signals)
China achieving 5nm-equivalent domestic capacity at production scale
US-EU trade dispute pulling decoupling resources away from China focus
Biotech/pharma carve-outs that signal decoupling appetite is narrower than assumed
§ Watch metrics — quantitative
Specific thresholds with current values.
Quantitative watch metrics not yet authored. This section will carry specific named metrics with their threshold levels and current values — the at-a-glance dashboard that turns a description into a tracker.
Key differenceCold War End converged previously-bifurcated economies; this REVERSES that. Same structural forces running backwards. Watch the unwinding sequence — it tracks 1989-2008 in reverse order (financial integration first, then trade, then alliances).
§ Related Lab findings
Where the mechanism is rigorously tested.
No Lab finding has been authored on this shift yet. The shift is tracked here as macro frame; rigorous mechanism testing comes when a finding is registered against the corpus.
§ Cross-shift interactions
Where this shift compounds or conflicts with another.
Defense-industrial decoupling is a primary lever in the broader US/China decoupling. The two shifts share supply-chain constraints and procurement-reform tailwinds.
Bifurcated space ecosystems (Chinese space station, lunar competition, navigation-system competition between GPS and BeiDou). Space is now a strategic-trade domain.
§ Track record
Prior calls + outcomes for this shift.
No prior calls logged for this shift yet. The track record builds over time as predictions resolve. It’s the credibility ledger — visible past calls and their outcomes, same way the Lab corpus tracks pre-registered predictions.